Identification of new therapeutic leads for triple negative breast cancer subtypes

被引：0
|
作者：
Robles, A. J. [1 ]
Du, L. [3 ]
Cai, S. [3 ]
Cichewicz, R. H. [3 ]
Mooberry, S. L. [1 ,2 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA
[3] Univ Oklahoma, Inst Nat Prod Applicat & Res Technol, Nat Prod Discovery Grp, Norman, OK 73019 USA
来源：
PLANTA MEDICA | 2015年 / 81卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q94 [植物学];
学科分类号：
071001 ;
摘要：
PH4
引用
收藏
页码：890 / 890
页数：1
相关论文
共 50 条
  • [31] Incidence and histological subtypes of triple-negative breast cancer
    Marian, C.
    Boros, M.
    Podeanu, M. D.
    Stolnicu, S.
    VIRCHOWS ARCHIV, 2011, 459 : S84 - S84
  • [32] Prospective analysis of molecular subtypes in triple negative breast cancer
    Vetter, Martina
    Hartung, Carolin
    Lantzsch, Tilmann
    Hanf, Volker
    Uleer, Christoph
    Peschel, Susanne
    John, Jutta
    Buchmann, Joerg
    Weigert, Edith
    Buerrig, Karl -Friedrich
    Kantelhardt, Eva-Johanna
    Thomssen, Christoph
    CANCER RESEARCH, 2020, 80 (04)
  • [33] Directed Therapy of Subtypes of Triple-Negative Breast Cancer
    Carey, Lisa A.
    ONCOLOGIST, 2010, 15 : 49 - 56
  • [34] Methylation signatures specific to triple negative breast cancer subtypes
    Kowalski, Jeanne
    Switchenko, Jeffery M.
    Dwivedi, Bhakti
    Nickleach, Dana
    Moreno, Carlos S.
    CANCER RESEARCH, 2013, 73
  • [35] Developing therapies for triple-negative breast cancer subtypes
    Okines, Alicia
    Turner, Nicholas
    LANCET ONCOLOGY, 2024, 25 (02): : 149 - 151
  • [36] MOLECULAR SUBTYPES IN BREAST CANCER: TRIPLE POSITIVE VERSUS TRIPLE NEGATIVE DISEASE
    Jeyaraj, P. A.
    Negi, P.
    Sachdeva, J.
    Williams, V.
    Marcus, S. S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E57 - E57
  • [37] Reverse phase protein array identification of triple-negative breast cancer subtypes and comparison with mRNA molecular subtypes
    Masuda, Hiroko
    Qi, Yuan
    Liu, Shuying
    Hayashi, Naoki
    Kogawa, Takahiro
    Hortobagyi, Gabriel N.
    Tripathy, Debu
    Ueno, Naoto T.
    ONCOTARGET, 2017, 8 (41) : 70481 - 70495
  • [38] ADAM17: A new therapeutic target for triple negative breast cancer?
    McGowan, P.
    Mullooly, M.
    Sukor, S.
    O'Donovan, N.
    Duffy, M. J.
    EJC SUPPLEMENTS, 2010, 8 (07): : 47 - 47
  • [39] Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
    Lehmann, Brian D.
    Colaprico, Antonio
    Silva, Tiago C.
    Chen, Jianjiao
    An, Hanbing
    Ban, Yuguang
    Huang, Hanchen
    Wang, Lily
    James, Jamaal L.
    Balko, Justin M.
    Gonzalez-Ericsson, Paula I.
    Sanders, Melinda E.
    Zhang, Bing
    Pietenpol, Jennifer A.
    Chen, X. Steven
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [40] Identification of BBOX1 as a therapeutic target in triple-negative breast cancer
    Liao, Chengheng
    Zhang, Yang
    Fan, Cheng
    Herring, Laura E.
    Liu, Juan
    Locasale, Jason W.
    Takada, Mamoru
    Zhou, Jin
    Zurlo, Giada
    Hu, Lianxin
    Simon, Jeremy M.
    Ptacek, Travis S.
    Andrianov, Victor G.
    Loza, Einars
    Peng, Yan
    Yang, Huanghe
    Perou, Charles M.
    Zhang, Qing
    CANCER RESEARCH, 2021, 81 (04)
12345